Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Alfieri

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|July 20, 2016
New therapeutic strategies for malignant pleural mesotheliomaMara A Bonelli, Claudia Fumarola, Silvia La Monica, et al.
Cancers|July 2, 2021
Immunotherapeutic Approaches in Malignant Pleural MesotheliomaRita Terenziani, Silvia Zoppi, Claudia Fumarola, et al.
Biochemical Pharmacology|June 7, 2021
Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistryLaura Scalvini, Riccardo Castelli, Silvia La Monica, et al.
Cells|February 15, 2022
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung CancerKamal Eltayeb, Silvia La Monica, Marcello Tiseo, et al.
Biotechnology Advances|August 23, 2011
Systems biology of the metabolic network regulated by the Akt pathwayEttore Mosca, Matteo Barcella, Roberta Alfieri, et al.
BMC Systems Biology|June 8, 2010
A multilevel data integration resource for breast cancer studyEttore Mosca, Roberta Alfieri, Ivan Merelli, et al.
Frontiers in Physiology|November 28, 2012
Computational modeling of the metabolic States regulated by the kinase aktEttore Mosca, Roberta Alfieri, Carlo Maj, et al.
Developmental and Comparative Immunology|April 25, 2020
Ribosome profiling unveils translational regulation of metabolic enzymes in primary CD4<sup>+</sup> Th1 cellsNicola Manfrini, Sara Ricciardi, Roberta Alfieri, et al.
Biochemical Society Transactions|December 4, 2016
Translational control by mTOR-independent routes: how eIF6 organizes metabolismAnnarita Miluzio, Sara Ricciardi, Nicola Manfrini, et al.
Critical Reviews in Oncology/Hematology|December 2, 2019
Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectivesSara Elena Rebuzzi, Roberta Alfieri, Silvia La Monica, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|July 20, 2016
New therapeutic strategies for malignant pleural mesotheliomaMara A Bonelli, Claudia Fumarola, Silvia La Monica, et al.
Cancers|July 2, 2021
Immunotherapeutic Approaches in Malignant Pleural MesotheliomaRita Terenziani, Silvia Zoppi, Claudia Fumarola, et al.
Biochemical Pharmacology|June 7, 2021
Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistryLaura Scalvini, Riccardo Castelli, Silvia La Monica, et al.
Cells|February 15, 2022
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung CancerKamal Eltayeb, Silvia La Monica, Marcello Tiseo, et al.
Biotechnology Advances|August 23, 2011
Systems biology of the metabolic network regulated by the Akt pathwayEttore Mosca, Matteo Barcella, Roberta Alfieri, et al.
BMC Systems Biology|June 8, 2010
A multilevel data integration resource for breast cancer studyEttore Mosca, Roberta Alfieri, Ivan Merelli, et al.
Frontiers in Physiology|November 28, 2012
Computational modeling of the metabolic States regulated by the kinase aktEttore Mosca, Roberta Alfieri, Carlo Maj, et al.
Developmental and Comparative Immunology|April 25, 2020
Ribosome profiling unveils translational regulation of metabolic enzymes in primary CD4<sup>+</sup> Th1 cellsNicola Manfrini, Sara Ricciardi, Roberta Alfieri, et al.
Biochemical Society Transactions|December 4, 2016
Translational control by mTOR-independent routes: how eIF6 organizes metabolismAnnarita Miluzio, Sara Ricciardi, Nicola Manfrini, et al.
Critical Reviews in Oncology/Hematology|December 2, 2019
Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectivesSara Elena Rebuzzi, Roberta Alfieri, Silvia La Monica, et al.
Pageof 10